Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

Share Price is delayed by 15 minutes
Get Live Data
442.60    -11.60 (-2.55%)
Bid:
442.40
Ask:
443.60
Spread: 1.20 (0.271%)
Market Cap: £1.09b
VSVS Live PriceLast checked at - London Stock Exchange

Intraday Vesuvius Share Chart

Share Buyback Programme

19 Nov 2024 07:00

Vesuvius Plc - Share Buyback Programme

Vesuvius Plc - Share Buyback Programme

PR Newswire

LONDON, United Kingdom, November 19

 

 

19 November 2024

 

Vesuvius plc

Launch of £50m Share Buyback Programme

 

Vesuvius plc ("Vesuvius"), a global leader in molten metal flow engineering and technology, is pleased to announce the commencement today of a further share buyback programme of up to £50 million (the "Programme"). The Programme will begin today, and will end no later than 23 July 2025, albeit it is targeted to be completed by late May 2025, subject to regulatory limits and market conditions.

 

The Programme is a continuation of the fulfilment of Vesuvius' commitment to return surplus cash to shareholders, following the successful completion of its initial £50m Share Buyback Programme at the end of August.

 

The sole purpose of the Programme is to reduce Vesuvius' share capital. The board of directors of Vesuvius (the "Board") has decided that the shares purchased pursuant to the Programme will be cancelled.

 

The Programme will be conducted within the limitations of the authority granted to the Board by its shareholders at its Annual General Meeting held on 15 May 2024, pursuant to which the maximum number of ordinary shares that can be bought back by Vesuvius is 26,809,383 shares. The aggregate purchase price of all ordinary shares acquired under the Programme will be no more than £50 million (excluding stamp duty and expenses).

 

Any purchases of ordinary shares in relation to the Programme will be carried out on the open market via the London Stock Exchange and/or on Aquis Exchange, Turquoise or CBOE Europe Limited. Any purchases will be made in accordance with the parameters prescribed by the Market Abuse Regulation 596/2014 (as it forms part of UK domestic law) and UKLR9.6 of the Financial Conduct Authority's Listing Rules.

 

Purchases of ordinary shares will be made by J.P. Morgan Securities plc ("JPMS plc") on Vesuvius' behalf, who shall lead manage the purchases, shall have full discretion with respect to the execution of all purchases (including but not limited to trading decisions concerning the timing of the purchase of the ordinary shares being made independently of Vesuvius) and shall make all such purchases independently of, and uninfluenced by Vesuvius. JPMS plc may undertake transactions in Shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by JPMS plc as a result of or as part of the Programme, but JPMS plc will continue to make any disclosures it is otherwise legally required to make.

 

Any market repurchase of ordinary shares will be announced no later than 7.30am on the business day following the calendar day on which the repurchase occurred.

 

For further information, please contact:

 

Enquiries:

 

 

Vesuvius plc

Rachel Stevens, Head of Investor Relations

+44 (0) 7387 545 271

 

 

 

 

 

MHP Communications

Rachel Farrington, Ollie Hoare

+44 (0) 203 128 8100

 

 

 

 

 

 

 

 

 

About Vesuvius plc

Vesuvius is a global leader in molten metal flow engineering and technology principally serving process industries operating in challenging high temperature conditions.

 

We develop innovative and customised solutions, often used in extremely demanding industrial environments, which enable our customers to make their manufacturing processes safer, more efficient and more sustainable.  These include flow control solutions, advanced refractories and other consumable products and increasingly, related technical services including data capture.

 

We have a worldwide presence. We serve our customers through a network of cost-efficient manufacturing plants located close to their own facilities, and embed our industry experts within their operations, who are all supported by our global technology centres.

 

Our core competitive strengths are our market and technology leadership, strong customer relationships, well established presence in developing markets and our global reach, all of which facilitate the expansion of our addressable markets.

 

Our ultimate goal is to create value for our customers, and to deliver sustainable, profitable growth for our shareholders giving a superior return on their investment whilst providing each of our employees with a safe workplace where they are recognised, developed and properly rewarded.

 

We think beyond today to create solutions that will shape the future.

 

Forward looking statements

This announcement contains certain forward looking statements which may include reference to one or more of the following: the Vesuvius' and/or the Vesuvius Group's (the "Group") financial condition, results of operations, cash flows, dividends, financing plans, business strategies, operating efficiencies or synergies, budgets, capital and other expenditures, competitive positions, growth opportunities for existing products, plans and objectives of management and other matters.

 

Statements in this announcement that are not historical facts are hereby identified as "forward looking statements". Such forward looking statements, including, without limitation, those relating to the future business prospects, revenue, working capital, liquidity, capital needs, interest costs and income, in each case relating to Vesuvius and/or the Group, wherever they occur in this announcement, are necessarily based on assumptions reflecting the views of Vesuvius and/or the Group and involve a number of known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by the forward looking statements. Such forward looking statements should, therefore, be considered in light of various important factors that could cause actual results to differ materially from estimates or projections contained in the forward looking statements. These include without limitation: economic and business cycles; the terms and conditions of Vesuvius' and/or the Group's financing arrangements; foreign currency rate fluctuations; competition in Vesuvius' and/or the Group's principal markets; acquisitions or disposals of businesses or assets; and trends in Vesuvius' and/or the Group's principal industries.

 

The foregoing list of important factors is not exhaustive. When considering forward looking statements, careful consideration should be given to the foregoing factors and other uncertainties and events, as well as factors described in documents that Vesuvius and/or the Group files with the UK regulator from time to time including its annual reports and accounts.

 

You should not place undue reliance on such forward looking statements which speak only as of the date on which they are made. Except as required by the Rules of the UK Listing Authority and the London Stock Exchange and applicable law, Vesuvius and/or the Group undertakes no obligation to update publicly or revise any forward looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward looking events discussed in this announcement might not occur. 

 

Vesuvius plc, 165 Fleet Street, London EC4A 2AE

Registered in England and Wales No. 8217766

LEI: 213800ORZ521W585SY02

www.vesuvius.com



Date   Source Headline
28th May 20131:44 pmRNSHolding(s) in Company
22nd May 201310:02 amRNSHolding(s) in Company
17th May 20137:00 amRNSInterim Management Statement
24th Apr 20133:56 pmRNSDirector/PDMR Shareholding
23rd Apr 20131:59 pmRNSDirector/PDMR Shareholding
23rd Apr 20139:55 amRNSAnnual Financial Report
23rd Apr 20139:49 amRNSDirector/PDMR Shareholding
23rd Apr 20139:36 amRNSDirector/PDMR Shareholding
19th Apr 201311:41 amRNSDirector/PDMR Shareholding
17th Apr 20133:16 pmRNSDirector Declaration
10th Apr 20134:22 pmRNSDirector/PDMR Shareholding
10th Apr 20133:06 pmRNSDirector/PDMR Shareholding
8th Apr 20131:47 pmRNSDirector/PDMR Shareholding
4th Apr 201312:29 pmRNSDirector/PDMR Shareholding
4th Apr 201312:09 pmRNSHolding(s) in Company
4th Apr 201312:06 pmRNSHolding(s) in Company
2nd Apr 20134:33 pmRNSTotal Voting Rights
28th Mar 20131:38 pmRNSDirector/PDMR Shareholding
27th Mar 20137:00 amRNSDisposal
21st Mar 20137:00 amRNSFinal Results
14th Mar 201311:31 amRNSHolding(s) in Company
11th Mar 20132:58 pmRNSHolding(s) in Company
8th Mar 20133:39 pmRNSDirector Declaration
1st Mar 20137:00 amRNSDirectorate Change
19th Feb 20138:39 amRNSHolding(s) in Company
4th Feb 20134:50 pmRNSDirector Declaration
30th Jan 20133:57 pmRNSHolding(s) in Company
21st Jan 201310:17 amRNSVesuvius extends Pensioner buy-in arrangement
15th Jan 20133:12 pmRNSHolding(s) in Company
10th Jan 201310:33 amRNSTotal Voting Rights
10th Jan 20139:52 amRNSHolding(s) in Company
9th Jan 20134:01 pmRNSBlock Listing Application
20th Dec 20125:10 pmRNSHolding(s) in Company
19th Dec 20125:38 pmRNSHolding(s) in Company
19th Dec 20127:00 amRNSDemerger Effective
18th Dec 20125:50 pmRNSVesuvius Reduction of Capital Effective
17th Dec 20128:00 amRNSVesuvius Admission
17th Dec 20127:00 amRNSScheme of arrangement
13th Dec 20123:20 pmRNSHolding(s) in Company
3rd Dec 201210:36 amRNSTotal Voting Rights
30th Nov 20124:51 pmRNSHolding(s) in Company
29th Nov 20127:00 amRNSDirectorate Change
29th Nov 20127:00 amRNSVesuvius plc Capital Markets Day
27th Nov 20127:00 amRNSDirectorate Change
27th Nov 20127:00 amRNSAlent plc Capital Markets Day
26th Nov 20123:15 pmRNSEGM Statement
19th Nov 201211:40 amRNSHolding(s) in Company
7th Nov 201211:44 amRNSAnalyst Presentation - Change of date
5th Nov 20121:59 pmRNSHolding(s) in Company
1st Nov 20122:37 pmRNSPublication & posting of documents

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.